The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections.
about
Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infectionsEvidence that verotoxins (Shiga-like toxins) from Escherichia coli bind to P blood group antigens of human erythrocytes in vitroCytoplasmic vacuolization in cell death and survivalAtypical hemolytic uremic syndrome: from diagnosis to treatmentHaemolytic-uraemic syndrome with thrombotic microangiopathy of the retina following cytomegalovirus infection: postmortem findingsHaemolytic uraemic syndrome.Humoral immune response to Shiga Toxin 2 (Stx2) among Brazilian urban children with hemolytic uremic syndrome and healthy controls.Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm?Characterization of the baboon responses to Shiga-like toxin: descriptive study of a new primate model of toxic responses to Stx-1Experimental verocytotoxemia in rabbitsShiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro.Administration of ricin induces a severe inflammatory response via nonredundant stimulation of ERK, JNK, and P38 MAPK and provides a mouse model of hemolytic uremic syndrome.Differences in virulence among Escherichia coli O157:H7 strains isolated from humans during disease outbreaks and from healthy cattleInteractions between Shiga toxins and human polymorphonuclear leukocytes.Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitroIntestinal damage in enterohemorrhagic Escherichia coli infection.Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease.A novel murine infection model for Shiga toxin-producing Escherichia coli.Shiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animals.Shiga toxin-associated hemolytic uremic syndrome complicated by intestinal perforation in a child with typical hemolytic uremic syndrome.L-arginine/NO pathway is altered in children with haemolytic-uraemic syndrome (HUS).Soluble plasma VE-cadherin concentrations are elevated in patients with STEC infection and haemolytic uraemic syndrome: a case-control studyShiga toxin-associated hemolytic uremic syndrome: effect of sodium butyrate on sensitivity of human umbilical vein endothelial cells to Shiga toxin.Enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Escherichia coli Vero cytotoxin 1Glomerular ultrastructural lesions of idiopathic cutaneous and renal glomerular vasculopathy of greyhounds.Acute respiratory failure in the hemolytic uremic syndrome.Comparison of the western blot assay with the neutralizing-antibody and enzyme-linked immunosorbent assays for measuring antibody to verocytotoxin 1.Verotoxin and ricin have novel effects on preproendothelin-1 expression but fail to modify nitric oxide synthase (ecNOS) expression and NO production in vascular endothelium.Monocyte chemoattractant protein-1 and interleukin-8 levels in urine and serum of patents with hemolytic uremic syndrome.Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipidThe detection of Shiga toxins in the kidney of a patient with hemolytic uremic syndrome.Comparison of the relative toxicities of Shiga-like toxins type I and type II for micePathogenesis of Escherichia coli O157:H7 strain 86-24 following oral infection of BALB/c mice with an intact commensal flora.Role of tumor necrosis factor alpha in gnotobiotic mice infected with an Escherichia coli O157:H7 strain.Cattle lack vascular receptors for Escherichia coli O157:H7 Shiga toxinsResponses of human intestinal microvascular endothelial cells to Shiga toxins 1 and 2 and pathogenesis of hemorrhagic colitis.Mouse toxicity and cytokine release by verotoxin 1 B subunit mutants.Shiga toxins induce, superinduce, and stabilize a variety of C-X-C chemokine mRNAs in intestinal epithelial cells, resulting in increased chemokine expressionShiga toxin translocation across intestinal epithelial cells is enhanced by neutrophil transmigration.Shiga-like toxin II derived from Escherichia coli O157:H7 modifies renal handling of levofloxacin in rats
P2860
Q24550740-1ECD561F-B044-4853-9FEE-247B3783886CQ24633154-0E2AAA99-AC72-4352-9DCC-EFDD6782F3BAQ26743410-7A44EE26-B016-4713-82D5-49C3134EDFDCQ27023137-DA7833F1-B8B6-496C-842E-A915BA464A35Q27486183-3154CD34-501F-458F-8797-30BAE8344513Q30244707-03D20EAC-216E-4064-B880-7417F6C8716FQ31165106-E13DDDA6-FD79-4D7D-A0D3-EBC907C2D646Q33302118-6CAB877A-A2AB-4C21-9C9E-77D70A7AD19EQ33328717-1C39AD16-3E3A-4563-A39D-57C3FD2D22C4Q33353985-9BD60024-E24A-4E1F-82A2-6BF41E0B7929Q33363208-8F159136-1F55-4C78-A3C4-F1D8A9EF84EBQ33364401-611F9CB5-EFB3-45C0-AF33-37C68D81E01EQ33376766-58248442-3B4E-4646-8281-AF9B7EC547C2Q33380350-1C83E9DF-0A14-4481-AD36-D5A32A500C40Q33384145-FA8FB2E4-5374-4A17-A6D7-A359464158B4Q33391718-BB22010B-677F-48BE-B408-041B3115C7BEQ33394010-341D2C54-6A83-4112-B8BB-13E7D8573525Q33403695-6F410D7E-B25A-4EB7-BB3C-0A2F136739C9Q33404640-4FD202BE-1C10-478B-B324-16FE17BB3DE1Q33414295-8B24757A-26A6-4602-96B3-D07A34E70CF1Q33414804-F0F6DD58-CC8B-4A8B-8AD3-46D52D9FAEA1Q33421074-FB3E8119-A3D5-4B2E-B1C3-E0D08126FB93Q33489940-3F7AB884-A2D5-4A4A-B429-ED5E239F91A5Q33492004-171CC25B-3EB2-4E9B-95BA-EA04B5A04E07Q33495323-7DBFE533-3266-4CD8-9963-6811B51BFDA5Q33495988-13059618-1785-4D15-9F04-E43C2DB2F528Q33498518-A3350127-77D7-410A-8EF6-C84C3982804FQ33501391-3A046322-0CC1-48A9-9CFA-67BF67EB2005Q33502724-4882EDE4-1832-46EE-BB1A-25B8B6B525BAQ33503400-5E7A2265-BBC7-44B2-9893-6E2D23FA8CB9Q33504952-7AD3D6BB-CD7C-4943-B8CD-F2B032679B57Q33605233-9D5C05D6-3B2E-441D-9103-1D845A863E88Q33712512-A4544BDC-F00B-4867-96B4-299B950BFD30Q33748229-F332F722-FE01-4746-91D2-D10334A859B7Q33916632-B02A168E-01B6-4DA6-9870-0CCA5B44D240Q34000714-AC455F5F-C7A9-4F53-955F-072429AE9906Q34005780-E6E84F5D-8D6A-43D2-9857-DE78C40F1579Q34009265-A26E0741-F040-4C5F-8F31-72199DB9D665Q34009274-DAC0443A-358C-4342-A18F-860FDA9AA81AQ34106589-EE608A1D-FC40-4946-8F48-F0D3D6D8D341
P2860
The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections.
description
1988 nî lūn-bûn
@nan
1988 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
The histopathology of the hemo ...... g Escherichia coli infections.
@ast
The histopathology of the hemo ...... g Escherichia coli infections.
@en
type
label
The histopathology of the hemo ...... g Escherichia coli infections.
@ast
The histopathology of the hemo ...... g Escherichia coli infections.
@en
prefLabel
The histopathology of the hemo ...... g Escherichia coli infections.
@ast
The histopathology of the hemo ...... g Escherichia coli infections.
@en
P2093
P1433
P1476
The histopathology of the hemo ...... ng Escherichia coli infections
@en
P2093
L E Becker
S E Richardson
P304
P356
10.1016/S0046-8177(88)80093-5
P407
P577
1988-09-01T00:00:00Z